搜索结果

疾病ID:TCMBANKDI012425

疾病名:Nephritis, Interstitial

MeSH_Name:Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases

HPO_Name:-

UMLS_Name:Disease or Syndrome

DO_Name:disease of anatomical entity

疾病类型:disease

DisGeNET_Link:C0027707

MeSH_Link:C13; C12

HPO_Link:-

UMLS_Link:T047

DO_Link:DOID:7

HERB_ID:-

   疾病对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族
   疾病对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN058205 trans-resveratrol (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene C14H12O3 228.24 g/mol C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
   疾病对应的靶点
靶点ID 基因名 基因别名 描述
TCMBANKGE000473 TRPC6 FSGS2; TRP6 transient receptor potential cation channel subfamily C member 6
TCMBANKGE000562 IL18 IGIF; IL-18; IL-1g; IL1F4 interleukin 18
TCMBANKGE009128 CCL1 I-309; P500; SCYA1; SISe; TCA3 C-C motif chemokine ligand 1
TCMBANKGE006975 THBS1 THBS; THBS-1; TSP; TSP-1; TSP1 thrombospondin 1
TCMBANKGE000029 GZMB C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT granzyme B
TCMBANKGE000883 MIR25 MIRN25; hsa-mir-25; miR-25 microRNA 25
TCMBANKGE000173 BRAF B-RAF1; B-raf; BRAF1; NS7; RAFB1 B-Raf proto-oncogene, serine/threonine kinase
TCMBANKGE004616 RBM45 DRB1; RB-1 RNA binding motif protein 45
TCMBANKGE000653 TCF7L2 TCF-4; TCF4 transcription factor 7 like 2
TCMBANKGE006656 B2M IMD43 beta-2-microglobulin
TCMBANKGE000274 CCL2 GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF C-C motif chemokine ligand 2
TCMBANKGE009021 HLA-DQB1 CELIAC1; HLA-DQB; IDDM1 major histocompatibility complex, class II, DQ beta 1
TCMBANKGE008915 RNLS C10orf59; RENALASE renalase, FAD dependent amine oxidase
TCMBANKGE013872 HSPG2 HSPG; PLC; PRCAN; SJA; SJS; SJS1 heparan sulfate proteoglycan 2
TCMBANKGE008568 SERPINB9 CAP-3; CAP3; PI-9; PI9 serpin family B member 9
TCMBANKGE010653 FLI1 BDPLT21; EWSR2; SIC-1 Fli-1 proto-oncogene, ETS transcription factor
TCMBANKGE000205 NOS2 HEP-NOS; INOS; NOS; NOS2A nitric oxide synthase 2
TCMBANKGE004436 SLC4A1 AE1; BND3; CD233; CHC; DI; EMPB3; EPB3; FR; RTA1A; SAO; SPH4; SW; WD; WD1; WR solute carrier family 4 member 1 (Diego blood group)
TCMBANKGE014498 XDH XAN1; XO; XOR xanthine dehydrogenase
TCMBANKGE013433 FLII FLI; FLIL; Fli1 FLII actin remodeling protein
TCMBANKGE000258 EGR1 AT225; G0S30; KROX-24; NGFI-A; TIS8; ZIF-268; ZNF225 early growth response 1
TCMBANKGE009334 SDC2 CD362; HSPG; HSPG1; SYND2 syndecan 2
TCMBANKGE000674 PDCD1 CD279; PD-1; PD1; SLEB2; hPD-1; hPD-l; hSLE1 programmed cell death 1
TCMBANKGE003970 SDC1 CD138; SDC; SYND1; syndecan syndecan 1
TCMBANKGE006832 IGHG3 IgG3 immunoglobulin heavy constant gamma 3 (G3m marker)
TCMBANKGE000589 CD68 GP110; LAMP4; SCARD1 CD68 molecule
TCMBANKGE001069 MPO - myeloperoxidase
TCMBANKGE000901 ANGPT1 AGP1; AGPT; ANG1 angiopoietin 1
TCMBANKGE010788 ATP6V1B1 ATP6B1; RTA1B; VATB; VMA2; VPP3 ATPase H+ transporting V1 subunit B1
TCMBANKGE005082 APOA1 HPALP2; apo(a) apolipoprotein A1
TCMBANKGE011031 CYP2C9 CPC9; CYP2C; CYP2C10; CYPIIC9; P450IIC9 cytochrome P450 family 2 subfamily C member 9
TCMBANKGE001161 IL2 IL-2; TCGF; lymphokine interleukin 2
TCMBANKGE003789 HLA-DQA1 CELIAC1; DQ-A1; DQA1; HLA-DQA major histocompatibility complex, class II, DQ alpha 1
TCMBANKGE012230 CNDP1 CN1; CPGL2; HsT2308 carnosine dipeptidase 1
TCMBANKGE011066 SLC16A12 CJMG; CRT2; CTRCT47; MCT12 solute carrier family 16 member 12
TCMBANKGE014480 CCL7 FIC; MARC; MCP-3; MCP3; NC28; SCYA6; SCYA7 C-C motif chemokine ligand 7
TCMBANKGE000224 AGT ANHU; SERPINA8; hFLT1 angiotensinogen
TCMBANKGE012843 EDN3 ET-3; ET3; HSCR4; PPET3; WS4B endothelin 3
TCMBANKGE008996 FAN1 KIAA1018; KMIN; MTMR15; hFAN1 FANCD2 and FANCI associated nuclease 1
TCMBANKGE005666 DCN CSCD; DSPG2; PG40; PGII; PGS2; SLRR1B decorin
TCMBANKGE009342 F10 FX; FXA coagulation factor X
TCMBANKGE006871 PLA2R1 CLEC13C; PLA2-R; PLA2G1R; PLA2IR; PLA2R phospholipase A2 receptor 1
TCMBANKGE001599 SLC3A1 ATR1; CSNU1; D2H; NBAT; RBAT solute carrier family 3 member 1
TCMBANKGE013973 SLC7A9 BAT1; CSNU3 solute carrier family 7 member 9
TCMBANKGE014567 SLC12A3 NCC; NCCT; TSC solute carrier family 12 member 3
TCMBANKGE006941 IGSF3 EWI-3; LCDD; V8 immunoglobulin superfamily member 3
TCMBANKGE011342 NGF Beta-NGF; HSAN5; NGFB nerve growth factor
TCMBANKGE002743 APOL1 APO-L; APOL; APOL-I; FSGS4 apolipoprotein L1
TCMBANKGE005662 ALB HSA; PRO0883; PRO0903; PRO1341 albumin
TCMBANKGE001021 MUC1 ADMCKD; ADMCKD1; CA 15-3; CD227; EMA; H23AG; KL-6; MAM6; MCD; MCKD; MCKD1; MUC-1; MUC-1/SEC; MUC-1/X; MUC1/ZD; PEM; PEMT; PUM mucin 1, cell surface associated
TCMBANKGE001012 FOXP3 AIID; DIETER; IPEX; JM2; PIDX; XPID forkhead box P3
TCMBANKGE009742 HLA-DRB1 DRB1; HLA-DR1B; HLA-DRB; SS1 major histocompatibility complex, class II, DR beta 1
TCMBANKGE006003 APRT AMP; APRTD adenine phosphoribosyltransferase
TCMBANKGE000251 FGF2 BFGF; FGF-2; FGFB; HBGF-2 fibroblast growth factor 2
TCMBANKGE010277 CYP2D6 CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1 cytochrome P450 family 2 subfamily D member 6
TCMBANKGE006724 REN HNFJ2 renin
TCMBANKGE000219 CCR5 CC-CKR-5; CCCKR5; CCR-5; CD195; CKR-5; CKR5; CMKBR5; IDDM22 C-C motif chemokine receptor 5
TCMBANKGE000276 NOS1 IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS nitric oxide synthase 1
TCMBANKGE000358 GLA GALA galactosidase alpha
TCMBANKGE011723 DHCR7 SLOS 7-dehydrocholesterol reductase
TCMBANKGE008183 ACE ACE1; CD143; DCP; DCP1 angiotensin I converting enzyme
TCMBANKGE002310 SEC61A1 HNFJ4; HSEC61; SEC61; SEC61A SEC61 translocon subunit alpha 1
TCMBANKGE013506 CLCN5 CLC5; CLCK2; ClC-5; DENTS; NPHL1; NPHL2; XLRH; XRN; hCIC-K2 chloride voltage-gated channel 5
TCMBANKGE013151 TM7SF2 ANG1; C14SR; DHCR14A; NET47 transmembrane 7 superfamily member 2
TCMBANKGE000315 IL4 BCGF-1; BCGF1; BSF-1; BSF1; IL-4 interleukin 4

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇IICP备16009434号-1 | Dai SX Lab